These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 1537780

  • 1. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
    DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P.
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):45-9. PubMed ID: 1537780
    [Abstract] [Full Text] [Related]

  • 2. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 3. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
    Pato MT, Hill JL, Murphy DL.
    Psychopharmacol Bull; 1990 Jul; 26(2):211-4. PubMed ID: 2236458
    [Abstract] [Full Text] [Related]

  • 4. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [Abstract] [Full Text] [Related]

  • 5. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD, Libb JW, Spitler D.
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [Abstract] [Full Text] [Related]

  • 6. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S.
    Psychopharmacol Bull; 1990 Jun; 26(1):54-9. PubMed ID: 2196627
    [Abstract] [Full Text] [Related]

  • 7. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [Abstract] [Full Text] [Related]

  • 8. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R, McLeod DR, Zimmerli WD, Hipsley PA.
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 10. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
    Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD, Johnson BR, Lucas JP.
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.